Intravesical Meglumine Gamma-Linolenic Acid in Superficial Bladder Cancer: An Efficacy Study
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in European Urology
- Vol. 42 (1) , 39-42
- https://doi.org/10.1016/s0302-2838(02)00208-7
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Effect of γ-linolenic acid on cellular uptake of structurally related anthracyclines in human drug sensitive and multidrug resistant bladder and breast cancer cell linesEuropean Journal Of Cancer, 1999
- Cytotoxic effects of two gamma linoleic salts (lithium gammalinolenate or meglumine gammalinolenate) alone or associated with a nitrosoureaAnti-Cancer Drugs, 1999
- Loss of δ6-desaturase activity leads to impaired docosahexaenoic acid synthesis in Y-79 retinoblastoma cellsProstaglandins, Leukotrienes & Essential Fatty Acids, 1998
- Bladder cancer recurrence by implantation of exfoliated cells: is gamma-linolenic acid an effective tumoricidal agent?BJU International, 1998
- Is gamma-linolenic acid an effective intravesical agent for superficial bladder cancer? In vitro cytotoxicity and in vivo tolerance studiesUrological Research, 1998
- Biosynthesis of unsaturated fatty acids in the main cell lineages of human leukemia and lymphomaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- n-3 and n-6 fatty acid processing and growth effects in neoplastic and non-cancerous human mammary epithelial cell linesBritish Journal of Cancer, 1994
- Alternative route for the biosynthesis of polyunsaturated fatty acids in K562 cellsBiochemical Journal, 1993
- Effect of polyunsaturated fatty acids on the drug sensitivity of human tumour cell lines resistant to either cisplatin or doxorubicinBritish Journal of Cancer, 1993
- Selective killing of human cancer cells by polyunsaturated fatty acidsProstaglandins, Leukotrienes and Medicine, 1985